Closed-Loop Insulin Delivery
Sometimes called an "artificial pancreas" system, this pairs a continuous glucose monitor with an insulin pump and an algorithm that automatically adjusts insulin delivery based on real-time glucose trends. Several systems are FDA-cleared and in real-world use, substantially reducing manual decision-making, though they still require calibration and clinical oversight rather than full autonomy.